肝移植治疗与酒精有关的肝病:不断变化的景观
Eda Yildiz1, Duha Zaffar2, N Begum Ozturk3
1Department of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hepatology forum
|April 18, 2025
概括
酒精性肝病 (ALD) 是一个不断增长的健康问题,通常需要肝移植 (LT). 早期肝移植 (ELT) 正在研究,作为选择性严重酒精相关肝炎患者的拯救生命的选择.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
- 公共卫生 公共卫生
背景情况:
- 酒精性肝病 (ALD) 是一个显著且日益增长的全球健康负担.
- 艾滋病是肝移植 (LT) 的主要原因之一.
- 目前的LT协议通常要求六个月的酒精戒断.
研究的目的:
- 评估早期肝移植 (ELT) 作为严重酒精相关性肝炎 (SAH) 的潜在治疗方法.
- 探索ELT在精选的ALD患者中的可行性,挑战传统的禁欲政策.
主要方法:
- 审查有关酒精性肝病早期肝移植的当前研究和临床实践.
- 对欧洲和美国接受ELT的高度精选的SAH患者的结果分析.
主要成果:
- 早期肝移植 (ELT) 正成为一种可行的,可能挽救生命的干预措施.
- 对于那些可能不符合标准禁欲标准的SAH患者,ELT为精心挑选的SAH患者提供了一个替代方案.
结论:
- 早期肝移植 (ELT) 在治疗严重酒精性肝病 (ALD) 方面表现有前途.
- 这种方法有可能为特定的,高度精选的患者队列重新塑造临床实践.
- 进一步的研究和仔细的患者选择对于ELT的成功实施至关重要.
相关概念视频
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


